Turn Therapeutics (TTRX) Common Equity (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Common Equity of $6.1 million for Q1 2026, up 647.22% year-over-year from $818710.0 in Q1 2025, and up 30.53% quarter-over-quarter from $4.7 million in Q4 2025.
Turn Therapeutics (TTRX) Common Equity (2024 - 2026) Analysis & Trends
Turn Therapeutics' Common Equity history runs 3 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Common Equity rose 647.22% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (up 647.22% YoY), while the FY2025 annual figure was $4.7 million, up 2741.42% from the prior year.
- Common Equity for Q1 2026 stood at $6.1 million, up from $4.7 million in the prior quarter.
- The five-year high for Common Equity was $6.1 million in Q1 2026, with the low at -$414299.0 in Q3 2024.
- The 3-year median for Common Equity is $435704.5 (2025), against an average of $1.8 million.
- Peak annual rise in Common Equity reached 2741.42% in 2025, while the deepest fall reached 112.72% in 2025.
- Turn Therapeutics' Common Equity stood at -$177432.0 in 2024, then surged by 2741.42% to $4.7 million in 2025, then soared by 30.53% to $6.1 million in 2026.
- Business Quant data shows TTRX's Common Equity at $6.1 million in Q1 2026, $4.7 million in Q4 2025, and $52699.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.61 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.17 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.79 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.35 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | 686,888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 686,888.00 |
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 52,699.00 |
| Mar 31, 2025 | 818,710.00 |
| Dec 31, 2024 | -177,432.00 |
| Sep 30, 2024 | -414,299.00 |